“…However, pretreatment with the p38 inhibitor SB203580, had no effect on ECFC proliferation. In this sense, although the role of p38 on the proliferation of EPC is still controversial, most of the studies using SB203580, in vitro and in vivo, have described a negative effect of this drug not only on cell growth and survival but also on tubulogenesis [41][42][43][44]. Interestingly, we also found that p38 blockade increased tubulogenesis in vitro at pH 7.4, suggesting that p38 pathway is a negative regulator of ECFC tubule formation and the fact that this molecule was completely suppressed in preconditioned ECFC explained, at least in part, the positive regulation of acidic preconditioning on microvessel formation.…”